Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Nov 29;19(1):100.
doi: 10.1186/s13223-023-00857-5.

Infantile atopic dermatitis and maternal-infant bonding: a mixed methods study

Affiliations

Infantile atopic dermatitis and maternal-infant bonding: a mixed methods study

Ayel Luis R Batac et al. Allergy Asthma Clin Immunol. .

Abstract

Background: Childhood atopic dermatitis can have a negative effect on caregivers' quality of life and stress levels due to the burdensome nature of its treatment. Given that the condition often emerges in infancy, atopic dermatitis-related stress also carries the potential to negatively affect the developing mother-infant bond. While it is plausible that atopic dermatitis has a negative impact on maternal-infant bonding, these relationships have not been studied directly. In light of this gap, the current study investigated the association between infantile atopic dermatitis and the maternal-infant bond using a mixed-method design.

Methods: Mothers of infants (< 19 months) with atopic dermatitis were recruited from social media and medical clinics between October 2021 and May 2022. Mothers with infants unaffected by inflammatory skin conditions were also recruited to serve as a control group. Participants were asked to complete questionnaires related to their demographics, child's health, and mother-infant bond. Multiple linear regression analyses were used to assess bonding quality among cases and controls. A subset of cases were also asked to participate in semi-structured interviews focused on infantile atopic dermatitis and the maternal-infant bond.

Results: The final sample consisted of 32 cases and 65 controls. Scores on the impaired bonding and risk of abuse subscales did not significantly differ between cases and controls. However, mothers of infants with atopic dermatitis did report lower levels of caregiving anxiety (b = - 1.47, p < 0.01) and pathological anger/rejection (b = - 1.74, p = 0.02) relative to controls. Qualitative findings suggest that the topical therapies required to manage atopic dermatitis may strengthen the bond between some mothers and infants.

Conclusion: Findings suggest that atopic dermatitis does not have a negative impact on maternal-infant bonding and may actually improve bonds in some cases. In light of this finding, clinicians may leverage the potentially positive impact of atopic dermatitis-related caregiving on the maternal-infant bond to encourage caregivers to remain adherent to their child's topical treatments.

Keywords: Atopic dermatitis; Maternal health; Maternal mental health; Maternal-infant bonding; Mixed methods; Postpartum bonding questionnaire.

PubMed Disclaimer

Conflict of interest statement

AB: sits on the Manitoba/Saskatchewan Steering Committee for ImmUnity Canada. KM, MG, MB, ZH, IK, EW, MJ, SE, MH, LR, JK-G, TG, JS,: none. EA: Section Head for Anaphylaxis and Food Allergy, and a Member of the Board, for the Canadian Society of Allergy and Clinical Immunology; and an employee of the Public Health Agency of Canada; the views expressed are her own and not those of the public health agency. ES: reports consultancy for Sanofi Genzyme. JP is Section Head, Allied Health; and Co-Lead, Research Pillar for the Canadian Society of Allergy and Clinical Immunology, and is on the steering committee for Canada’s National Food Allergy Action Plan. She reports consulting for Ajonomoto Cambrooke, Novartis, Nutricia and ALK Abelló.

Figures

Fig. 1
Fig. 1
Flow chart demonstrating the process of thematic analysis

References

    1. Frazier W, Bhardwaj N. Atopic dermatitis: diagnosis and treatment. Am Fam Physician. 2020;101(10):590–598. - PubMed
    1. Volke A, Toompere K, Laisaar K-T, Oona M, Tisler A, Johannson A, et al. 12-month prevalence of atopic dermatitis in resource-rich countries: a systematic review and meta-analysis. Sci Rep. 2022;12(1):15125. doi: 10.1038/s41598-022-19508-7. - DOI - PMC - PubMed
    1. Eichenfield LF, Tom WL, Berger TG, Krol A, Paller AS, Schwarzenberger K, et al. Guidelines of care for the management of atopic dermatitis: section 2. Management and treatment of atopic dermatitis with topical therapies. J Am Acad Dermatol. 2014;71(1):116–132. doi: 10.1016/j.jaad.2014.03.023. - DOI - PMC - PubMed
    1. Sidbury R, Davis DM, Cohen DE, Cordoro KM, Berger TG, Bergman JN, et al. Guidelines of care for the management of atopic dermatitis: section 3. Management and treatment with phototherapy and systemic agents. J Am Acad Dermatol. 2014;71(2):327–349. doi: 10.1016/j.jaad.2014.03.030. - DOI - PMC - PubMed
    1. Su JC, Kemp AS, Varigos GA, Nolan TM. Atopic eczema: its impact on the family and financial cost. Arch Dis Child. 1997;76(2):159–162. doi: 10.1136/adc.76.2.159. - DOI - PMC - PubMed

LinkOut - more resources